London Pharma & Chemicals Holdings Ltd
07080124
Healthy
- Going concern doubt noted in accounts (-10)
Details
Previously known as
Compliance
Last accounts
31/12/2025
group
Next accounts due
30/09/2027
Confirmation statement
Last: 23/01/2026
Due 06/02/2027
Industry
Officers
director · Since 03/12/2011
BUSINESS MANAGER
BRITISH · UNITED KINGDOM
Also on 15 other boards
director · Since 31/01/2017
COMPANY DIRECTOR
BRITISH · ENGLAND
Also on 5 other boards
Former
secretary · Resigned 18/08/2011
director · Resigned 03/12/2011
Persons with Significant Control
Mr Daniel Reuben Straus
British · United Kingdom
Notified 06/04/2016
Ms Claire Joanne Sharon Straus
British · England
Notified 06/04/2016
Change History
Active
Private Limited Company
UNIT 10, DELTA COURT
BOREHAMWOOD
CompanyRankvs 28+ SIC 70100 peers80
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going concer
Key FinancialsYear ending 31/12/2025
Net Worth
£58.0M
Balance sheet strength
Cash
£32.9M
Cash in the bank
Net Current Assets
£49.9M
Working capital
Current Assets
£76.0M
Current Liabilities
£26.1M
Fixed Assets
£8.2M
Debtors
£20.3M
Cost of Sales
£81.0M
Admin Expenses
£20.0M
Profit After Tax
£6.2M
Tax at Year End
People Costs
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.91 | +£7.2M |
| 2024 | — | +£50.7M |
Derived from filed accounts. Not audited figures.